NasdaqCM - Nasdaq Real Time Price USD

Telomir Pharmaceuticals, Inc. (TELO)

2.5000
+0.1400
+(5.93%)
At close: May 16 at 4:00:00 PM EDT
2.5000
0.00
(0.00%)
After hours: May 16 at 4:05:09 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -2.18M

Q4'24

Q1'25

-2M
-1M
0
 

Analyst Price Targets

15.25
15.25 Average
2.5000 Current
15.25 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate -0.08-0.08-0.31-0.28
Low Estimate -0.08-0.08-0.31-0.28
High Estimate -0.08-0.08-0.31-0.28
Year Ago EPS -----0.56-0.31

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate ------1.5M
Low Estimate ------1.5M
High Estimate ------1.5M
Year Ago Sales --------
Sales Growth (year/est) ----0.00%0.00%

Earnings History

Currency in USD 12/31/2024 3/31/2025
EPS Est. -0.05-0.1
EPS Actual -0.1-0.07
Difference -0.050.03
Surprise % -100.00%30.00%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.08-0.08-0.31-0.28
7 Days Ago -0.1-0.1-0.4-0.36
30 Days Ago -0.1-0.1-0.4-0.36
60 Days Ago -0.1-0.1-0.4-0.36
90 Days Ago -0.05-0.04-0.23-0.18

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days 1111
Down Last 30 Days 1111

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
TELO ----44.64%9.68%
S&P 500 13.31%2.69%7.81%13.74%

Related Tickers